Advancements have been made in the pain management field that have successfully found FDA approved alternatives to ...

Sen. Mark Kelly champions the PAIN Act to improve seniors' access to non-opioid pain treatments under Medicare.

A new opioid-free pain medication was approved by the FDA on Thursday, marking a non-addictive alternative for patients.

Non-opioid pain therapies are entering an unprecedented era, marked by the landmark FDA approval of Vertex’s Journavx and a ...

AlgoTherapeutix blames a “strong placebo effect” for the mid-stage failure for its pain gel ATX01, but the company still ...

Beyond wanting to create more effective drugs, the motivations for constant attempts to produce new, non-opioid painkillers are largely either commercial — because opioid availability is limited ...

The United States Food and Drug Administration (FDA) has approved a new non-opioid prescription medication, Journavx (suzetrigine), for adults with moderate to severe acute pain. Developed by ...

Chronic pain is complex and difficult to treat. Prescribing opioid pain medications has become controversial but may help ...

And the big headline here is that it’s not an opioid, and it’s non-addictive. So how does it work? Who should take it? Does it signal a new era for pain medication? Here to help break down this new ...

The Federal Drug Administration last month approved Journavx, a new kind of non-addictive pain medication. Doctors say Journavx is an important alternative because the power of opioids helped fuel an ...

They will if the generic drug is an opioid that carries the potential for addiction and the new medicine is a non-opioid that poses no such known risk. That’s the opinion of top Vertex ...